1,663.90002 INR
6
0.36%
Last update Dec 16, 3:28 PM IST
Market closed
Day range
1,662
1,684
Previous close
1,669.90002
Open
1,667
Access this stock data via API
Subscribe
Gland Pharma Ltd.
1,663.90
6
0.36%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 15.1B 13.9B 13.8B 14.1B
Cost of revenue 5.2B 4.9B 4.6B 5.8B
Gross profit 9.8B 9.0B 9.2B 8.3B
Operating expense
Research & development
Selling general and admin
Other operating expenses 2.1B 255.3M 2.2B 2.0B
Operating income 2.7B 2.5B 2.6B 2.0B
Non operating interest income
Income
Expense 115.0M 28.5M 228.2M 61.1M
Other income expense
Pretax income 3.1B 2.9B 3.0B 2.6B
Tax provision 972.6M 1.0B 946.1M 932.5M
Net income 2.2B 1.9B 2.0B 1.6B
Basic EPS 13.1 12.4 9.9
Diluted EPS 13.1 12.4 9.9
Basic average shares 164.7M 164.8M 164.7M
Diluted average shares 164.7M 164.8M 164.7M
EBITDA 4.3B 3.9B 4.2B 3.6B
Net income from continuing op.
Minority interests 0 0 0 0
Preferred stock dividends 0 0 0 0
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Main market opens in 13 hours 34 minutes

19:40
00:00
09:15
15:30
23:59

Trading Hours (Monday - Friday):

Main market
09:15 - 15:30
All times are displayed in the Asia/Kolkata timezone (IST, UTC+05:30).